OBJECTIVES: Previous research among American Indians of the strong heart family study (SHFS) has demonstrated significant heritabilities for CVD risk factors and implicated diabetes as an important predictor of several of the phenotypes. Moreover, we recently demonstrated that genetic effects on CVD risk factors differed in diabetic and nondiabetic individuals. In this paper, we investigated whether a significant genetic influence on diabetes status could be identified, and whether there is evidence for joint action of genes on diabetes status and related CVD risk factors.
Introduction
Cardiovascular disease (CVD) is the most common macrovascular complication of diabetes mellitus, accounting for 80% of deaths among diabetic individuals. 1, 2 The relation of diabetes to CVD and associated CVD risk factors has been the focus of recent research among American Indians of the Strong Heart Study (SHS). This longitudinal population-based study was initiated in 1988 to determine the prevalence and incidence of CVD in 13 American-Indian communities in three geographic regions (Arizona (AZ), Oklahoma (OK), and North and South Dakota (DK)), and to identify CVDassociated risk factors. A pilot family study was added in the third phase, the Strong Heart Family Study (SHFS), which was designed to localize genes influencing CVD risk factors in 30 large families (approximately 950 participants). Among American Indians of the SHS the prevalence of diabetes has reached epidemic proportions 3 and is believed to contribute to the increasing rates of CVD morbidity and mortality. 4, 5 Additionally, alarming increases in CVD risk factors across time have been reported. 3 Many CVD risk factor phenotypes are significantly heritable, and diabetes status has been identified as an important correlate of these risk factors in American Indians participating in the SHFS. 6 Moreover, we recently demonstrated that genetic effects on obesity and lipid-related CVD risk factors in the SHFS differed in diabetic and nondiabetic individuals. 7 The heritability of diabetes susceptibility has not been examined in American Indians of the SHFS. However, many studies have implicated a strong genetic component to variation in diabetes status. 8 Other evidence that diabetes has strong genetic determinants includes marked diseaserate differences between populations 9,10 and a close correspondence between genetic admixture rates and disease prevalence in hybrid populations. [11] [12] [13] Twin studies have demonstrated a high rate of concordance among monozygotic (MZ) twins. [14] [15] [16] [17] Additionally, family studies have established the contribution of a positive family history in the development of diabetes 18, 19 and a higher prevalence of diabetes in first, second, and third degree relatives in comparison to controls 20, 21 . All these studies are suggestive of a significant genetic component to diabetes susceptibility. In this study, we wished to determine if a significant genetic influence on diabetes status could be identified and whether there is evidence for the joint action of genes on diabetes status and related quantitative CVD risk factors in the American Indians of the SHFS. To accomplish these objectives, we first estimated the effects of genes and environmental covariates on diabetes susceptibility, using a threshold model and a maximum likelihood variance component approach. 22 We then used an extension of variance component methods to determine the genetic and environmental correlations between quantitative risk factors for CVD and discrete disease outcomes (diabetes status).
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Genetic and environmental correlations with diabetes susceptibility were assessed for eight CVD risk factors (body fat (FAT), body mass index (BMI), HDL cholesterol (HDL-C), ln fibrinogen, ln triglycerides, plasminogen activator inhibitor 1 (PAI-1), systolic blood pressure (SBP), and waist-to-hip ratio (WHR)).
Materials and methods

Strong heart study
The study design and methods of the SHS have been described previously. 24 The SHS is a longitudinal study with three clinical examinations and mortality and morbidity surveillance of resident tribal members aged 45-74 y (the cohort). During the baseline examination, conducted between 1989 and 1991, 4549 tribal members were examined. The second examination, conducted between 1993 and 1995, included 89% of the surviving members of the original cohort and the third examination, conducted in 1998-1999, included 88% of surviving members of the cohort. A pilot family study, the SHFS, was added in 1998 in which 8-12 extended families (more than 300 family members at least 18 y of age) were recruited and examined at each center. An extension of the pilot family study is currently in progress and will involve recruitment of approximately 90 additional families, for a total of 2700 new participants. Phenotypic, demographic, and lifestyle data The SHFS exam consisted of a personal interview, physical examination, laboratory tests, and a carotid ultrasound. Standard protocols were used for the collection of all data and are described in detail in previous publications 24, 25 .
Body fat mass was measured using an RJL bioelectric impedance meter and estimated by the RJL formula based on total body water. 26 Blood pressure was measured three times and the mean of the last two measurements was used for analysis.
Fasting blood samples were obtained during the physical examination for the measurement of lipids, lipoproteins, apolipoproteins, insulin, glucose, plasma creatinine, plasma fibrinogen, and PAI-1 24, 27 . All phenotypes were assayed at MedStar Research Institute, Washington, DC, using standard laboratory methods as previously described 24, 27 . The bquantification procedure for lipoprotein quantification, as described by the Lipid Research Clinics, was applied to these data for family study participants. For cohort participants, the b-estimation procedure for lipoprotein quantification was applied. 28 Triglycerides were measured using the Triglyceride-GB system pack for Hitachi 717. Fibrinogen was measured in an automated clot-rate assay based upon the original method of Clauss. 29 The ST4 Instrument (Diagnostica Stago), with standardization with the CAP reference material, was used to measure fibrinogen levels. PAI-1 was measured using a double antibody ELISA, originally developed by DeClerck et al. 30 This assay is sensitive to free PAI-1 (latent and active) and not to PAI-1 in complex with t-PA. The glucose tolerance test was performed only if the participant was not on insulin or any oral hypoglycemic medications for known diabetes and if the participant had a fasting glucose value less than 225 mg/dl (as determined by Acucek II, Baxter Healthcare, Grand Prairie, TX, USA). Diabetes (DM), impaired glucose tolerance (IGT), and normal glucose tolerance (NGT) status were determined according to the World Health Organization criteria. 31 Action of genes on diabetes status and CVD risk factors KE North et al All participants gave informed consent for this study, which was approved by the Institutional Review Boards of all of the participating institutions.
Statistical genetic methods
The phenotypic variance in CVD risk factors was partitioned into additive genetic and environmental variance components, 32 using maximum likelihood variance decomposition methods. [33] [34] [35] These univariate quantitative genetic analyses were performed using the computer package SOLAR. 36 The heritability of diabetes status was estimated using a pedigree-based maximum likelihood method that models affection status by a liability threshold model. 32, 22 Although disease status is a qualitative trait, with individuals scored as either affected or unaffected, the threshold model assumes there is an underlying quantitative liability to disease. If an individual's liability exceeds a specified threshold, the individual becomes affected. If an individual's liability is below the threshold, the individual is unaffected. Liabilities and the threshold value itself are estimated using age-and sex-specific parameters, and the population prevalence of the disease trait. We next used a mixed discrete-continuous trait variance component method for mixed traits to examine the genetic relation between diabetes susceptibility and quantitative variation in CVD risk factors. 23 Specifically, we estimated the genetic and environmental correlations between diabetes susceptibility and eight quantitative risk factors for CVD. P-values for estimated effects are obtained using likelihood ratio tests, where the likelihood of a given model is estimated and compared to the likelihood of the model in which the effect is absent. Twice the difference in the natural logarithmic likelihoods is asymptotically distributed as a 1/2 : 1/2 mixture of a w 2 variable with one degree of freedom and a point mass at zero. 37 Evidence consistent with pleiotropy (in which the same gene influences several traits) is indicated by additive genetic correlations that are significantly different from zero. The detection of significant shared genetic effects on multiple phenotypes can lead to hypotheses regarding the genetic regulation of complex phenotypes, identify possible constellations of genes underlying suites of complex phenotypes, and when major locus effects have been detected, generate tentative linkage hypotheses.
Application to SHFS data
To maximize the power to detect genetic correlations, our analyses used combined data from all three centers. We used the covariates sex, age, age-by-sex interaction, age 2 , age 2 -bysex interaction, and center, because these effects are common to both diabetes susceptibility and the CVD risk factors examined here. No additional covariate adjustments were made as previous studies have demonstrated a minimal reduction of the genetic signal for the traits examined here, when additionally adjusted for BMI and smoking status. 6 All individuals with impaired glucose tolerance (n ¼ 119) were excluded from these analyses. In total, 31 of 32 of the SHFS families had at least one affected participant, with a mean of 8.6 diabetics per family group (range between 4 and 17). The diabetic participants in these 31 families included a large number of relative pair types (Table 1) . A total of 4079 relation pairs included at least one diabetic participant with many instances of first degree (eg, siblings or parents and offspring), second degree (eg, avuncular pairs, grandparent-grandchild pairs), and third degree or greater relative pairs (eg, great-avuncular pairs, first cousin pairs, and second cousins). to include center as a covariate in all analyses to obtain an estimate of between-center differences. When larger sample sizes become available, independent analyses will be conducted in each center.
Heritability of diabetes status
Correlations between diabetes status and CVD risk factors
The descriptive statistics for cardiovascular disease-risk factors in diabetics and nondiabetics are reported in Table 2 . The genetic and environmental correlations of diabetes status with CVD risk factors are given in Table 3 . These correlations vary widely, but all CVD risk factors display a significant genetic correlation with diabetes status. In total, three of eight CVD risk factors (HDL-C, triglycerides, and fibrinogen) also show a significant environmental correlation with diabetes status. As all eight CVD risk factors displayed significant genetic correlations with diabetes status, we briefly examined whether other CVD risk factors would also show significant genetic correlations with diabetes status. For apolipoprotein B and LDL-C, no significant genetic correlation was detected (data not shown).
Discussion
Our previous analyses of American Indians from the SHFS have demonstrated significant heritabilities for obesity-, lipid-, clotting-, and blood pressure-related phenotypes and have implicated diabetes status as an important correlate. 6 Moreover, we recently demonstrated that genetic effects on obesity-and lipid-related CVD risk factors in the SHFS differed in diabetic and nondiabetic individuals. 7 Motivated by these findings, we were interested to determine if a significant genetic influence on diabetes status itself could be identified, and whether there is evidence for the joint action of genes on diabetes status and related quantitative CVD risk factors in the American Indians of the SHFS. In our previous analyses, only five traits (BMI, FAT, WHR, HDL-C, and ln triglycerides) showed evidence for distinct genetic effects in diabetic and nondiabetic individuals. However, high standard errors of parameter estimates were obtained for the three additional phenotypes, indicating low power of the sample.
In this study, after the effects of age, sex, age-by-sex interaction, and center have been accounted for, we have demonstrated a moderate additive genetic effect on diabetes status. To our knowledge, there are few published actual heritability estimates for diabetes status 8 . Nonetheless, there is strong evidence that diabetes has strong genetic determinants [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The identification of moderate genetic influences on diabetes status in the American Indians of the SHFS is important, not only in its own right, but also because diabetes status has been implicated as the best predictor of CVD. 5 We also found evidence for common genetic effects on diabetes status and eight obesity, lipid, clotting, and blood pressure traits. In fact, such pleiotropic action of genes is predicted in highly coordinated systems, such as in CVD risk factors (eg, HDL-C and BMI). Although no prior studies have reported genetic correlations between diabetes status and these CVD traits, studies have consistently demonstrated an effect of diabetes on obesity, 39, 40 lipids, [41] [42] [43] [44] clotting traits 45, 46 , and blood pressure measures. 47 In the American Indians of the SHFS, there is a high prevalence of diabetes. In Individuals taking cholesterol-lowering medications were not included in these analyses. b Individuals taking antihypertensive medications were not included in these analyses. For all phenotypes, all outliers were removed prior to analysis.
Action of genes on diabetes status and CVD risk factors KE North et al the context of this genetic, metabolic, and neuroendocrine background, it may be that a common genetic effect in diabetics, or a diabetes susceptibility gene, is an important influence on variation in CVD risk factors. Interestingly, six of the CVD risk factors that are indicative of gene-by-gene interaction with diabetes status are components of the metabolic syndrome, a cluster of metabolic abnormalities including central obesity, abnormal glucose tolerance, elevated insulin, and triglycerides, depressed HDL-C, and hypertension. [48] [49] [50] Previous studies have implicated a common underlying genetic factor influencing the development of the syndrome [50] [51] [52] [53] [54] [55] , and the suggestion of pleiotropy in diabetes status and some metabolic syndrome traits, is consistent with those findings. Future research will explore this relationship more closely by examining the clustering of the metabolic syndrome traits, and using these clusters in the calculation of heritabilities and in linkage analysis. Three traits, HDL-C, triglycerides, and fibrinogen, displayed significant environmental correlations with diabetes status. These findings are suggestive of common unmeasured residual effects (for example, diet and/or physical activity) on diabetes status and lipid and clotting levels. Although no other studies have reported an environmental correlation between diabetes status and lipid or clotting measures, relations between diabetes and lipid levels [56] [57] [58] and between diabetes and clotting variables 59, 60 have been consistently demonstrated. Lifestyle factors such as smoking, alcohol consumption, diet, and physical activity may also be implicated in these findings, as the residual variance can encompass any unmeasured environmental effect. Additionally, studies have consistently demonstrated an effect of smoking, alcohol consumption, diet, and physical activity on lipid levels 58, [61] [62] [63] [64] [65] [66] [67] and on fibrinogen levels. [68] [69] [70] [71] [72] [73] [74] Within the SHS populations, elevated triglyceride concentrations were significantly associated with the development of diabetes in men with normal glucose tolerance. 75 In addition, lifestyle factors such as smoking and physical activity have been shown to affect lipid levels. 25, 76 To maximize the number of individuals entering the analyses, our models included only age, age 2 , sex, and center as covariates. It would have been of interest to estimate the effect of diabetes duration; however, many individuals did not provide information on diabetes duration and we were unable to consider this effect.
Given the multiple comparisons presented in Table 3 , it might be argued that a correction for multiple tests was needed. Using a Bonferroni correction for eight comparisons, a P-value of 0.05/8 ¼ 0.00625 would be required to ensure the conventional 5% level of statistical significance over all traits 77 ). Using such an approach, only four of the eight genetic correlations would have been considered statistically significant (BMI, WHR, ln triglyceride, and PAI-1). However, this correction assumes that all of the comparisons are independent, which they are not in our study (eg, ln triglyceride and HDL-C).
In summary, a significant heritability of diabetes status, and several significant genetic and environmental interactions between diabetes status and eight CVD risk factors were demonstrated. We believe that this represents an important step in the understanding of the determinants of CVD risk factors. These findings will be important for future research, as statistical genetic models incorporating these interactions should better approximate the biological reality of the traits, and make it easier to detect, localize, and identify genes contributing to variation and covariation of CVD risk factors, and to measure their effects. These results are a first step in the search for CVD risk factor genes in American Indians. Future research will determine the chromosomal location of CVD risk factors genes and ultimately, functional polymorphisms associated with the variability will be identified. Tauqeer Ali, Alan Crawford, and the many collaborators and staff of the Strong Heart Study have made this project possible. We also thank Drs John Blangero, Laura Almasy, Tony Comuzzie, and Lisa Martin for their generous contribution to this research. This research was conducted while author (KEN) was a postdoctoral fellow at the Southwest Foundation for Biomedical Research and was funded by a cooperative agreement that includes Grants U01 HL65520, U01 HL41642, U01 HL41652, U01 HL41654, U01 HL65521 from the National Heart, Lung, and Blood Institute. The views expressed in this paper are those of the authors and do not necessarily reflect those of the Indian Health Service. Action of genes on diabetes status and CVD risk factors KE North et al
